Technical Analysis for MNKD - MannKind Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | 3.36% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 3.36% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 3.36% | |
Calm After Storm | Range Contraction | 3.36% | |
NR7 | Range Contraction | 3.36% | |
Wide Bands | Range Expansion | 3.36% | |
Calm After Storm | Range Contraction | 2.67% | |
Outside Day | Range Expansion | 2.67% | |
Wide Bands | Range Expansion | 2.67% |
Alert | Time |
---|---|
10 DMA Resistance | about 15 hours ago |
Up 5% | about 15 hours ago |
Up 1 ATR | about 15 hours ago |
Up 3% | about 17 hours ago |
Non-ADX 1,2,3,4 Pullback Entry | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/27/2024
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Insulin Endocrine System Hyperglycemia Inhaler
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Insulin Endocrine System Hyperglycemia Inhaler
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.75 |
52 Week Low | 3.17 |
Average Volume | 3,110,409 |
200-Day Moving Average | 4.06 |
50-Day Moving Average | 3.80 |
20-Day Moving Average | 4.30 |
10-Day Moving Average | 4.72 |
Average True Range | 0.25 |
RSI (14) | 59.68 |
ADX | 32.77 |
+DI | 33.54 |
-DI | 19.52 |
Chandelier Exit (Long, 3 ATRs) | 4.64 |
Chandelier Exit (Short, 3 ATRs) | 4.23 |
Upper Bollinger Bands | 5.37 |
Lower Bollinger Band | 3.24 |
Percent B (%b) | 0.65 |
BandWidth | 49.47 |
MACD Line | 0.27 |
MACD Signal Line | 0.28 |
MACD Histogram | -0.0189 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.12 | ||||
Resistance 3 (R3) | 5.10 | 4.92 | 5.03 | ||
Resistance 2 (R2) | 4.92 | 4.79 | 4.93 | 5.00 | |
Resistance 1 (R1) | 4.77 | 4.72 | 4.85 | 4.79 | 4.98 |
Pivot Point | 4.59 | 4.59 | 4.63 | 4.60 | 4.59 |
Support 1 (S1) | 4.44 | 4.46 | 4.52 | 4.46 | 4.26 |
Support 2 (S2) | 4.26 | 4.39 | 4.27 | 4.24 | |
Support 3 (S3) | 4.11 | 4.26 | 4.21 | ||
Support 4 (S4) | 4.13 |